The SIDER database of drugs and side effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most widely utilized ADE databases derived from drug label data is SIDER, constructed using a dictionary-based named entity recognition (NER) method to extract adverse event terms from FDA Structured Product Labeling (SPLs) drug labels13.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Self-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, it was shown that ADRs can be used to predict drug targets (1) and that causal relations between targets and ADRs can be elucidated (2,3).”
BackgroundSelf-citationThe Stanford typed dependencies representation
de Marneffe, M.-C., & Manning, C. D. (2008) · Coling 2008: Proceedings of the workshop on Cross-Framework and Cross-Domain Parser Evaluation - CrossParser '08 · doi:10.3115/1608858.1608859 · Cited by 918
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Self-citationPREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Self-citationExtraction of potential adverse drug events from medical case reports
Gurulingappa, H., Mateen‐Rajpu, A., & Toldo, L. (2012) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-3-15 · Cited by 211
The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text
Pafilis, E., Frankild, S. P., Fanini, L., Faulwetter, S., Pavloudi, C., Vasileiadou, A., Arvanitidis, C., & Jensen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065390 · Cited by 206
Self-citationCai, M., Xu, Q., Pan, Y.-J., Pan, W., Ji, N., Li, Y.-B., Jin, H.-J., Liu, K., & Ji, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1066 · Cited by 131
Systematic identification of proteins that elicit drug side effects
Kuhn, M., Al Banchaabouchi, M., Campillos, M., Jensen, L. J., Gross, C., Gavin, A., & Bork, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 120
Self-citation
Cited by
Items 501–600 of 1,001
Chen, R. K., Duffy, Á., Petrazzini, B. O., Vy, H. M. T., Stein, D. F., Mort, M. E., Park, J. K., Schlessinger, A., Itan, Y., Cooper, D. N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53333-y · Cited by 22
Shameer, K., Pérez-Rodríguez, M. M., Bachar, R., Li, L., Johnson, A. M., Johnson, K. W., Glicksberg, B. S., Smith, M. R., Readhead, B., Scarpa, J. R., et al. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0653-3 · Cited by 22
MoleculeFormer is a GCN-transformer architecture for molecular property prediction
Qin, M., Sun, Z., Feng, L., Han, C., Xia, J., & Han, L. (2025) · Communications Biology · doi:10.1038/s42003-025-09064-x · Cited by 22
Predicting combinative drug pairs via multiple classifier system with positive samples only
Shi, J., Li, J., Mao, K.-T., Cao, J.-B., Lei, P., Lu, H., & Yiu, S. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.11.002 · Cited by 22
Xie, L., He, S., Wen, Y., Bo, X., & Zhang, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-07705-8 · Cited by 22
A comprehensive integrated drug similarity resource for in-silico drug repositioning and beyond
Azad, A., Dinarvand, M., Nematollahi, A., Swift, J., Lutze-Mann, L. H., & Vafaee, F. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa126 · Cited by 22
MetaADEDB 2.0: a comprehensive database on adverse drug events
Yu, Z., Wu, Z., Li, W., Liu, G., & Tang, Y. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa973 · Cited by 22
Aspect extraction and classification for sentiment analysis in drug reviews
Imani, M., & Noferesti, S. (2022) · Journal of Intelligent Information Systems · doi:10.1007/s10844-022-00712-w · Cited by 22
Human genetic evidence enriched for side effects of approved drugs
Minikel, E. V., & Nelson, M. R. (2025) · PLoS Genetics · doi:10.1371/journal.pgen.1011638 · Cited by 21
Advancing biocompatible metal-organic frameworks in personalized biomedical applications
Yu, Z., Chivu, A., Dai, J., Patra, H. K., Zou, J., & Hu, Z. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217262 · Cited by 21
Ståhl, N., Falkman, G., Karlsson, A., Mathiason, G., & Boström, J. (2018) · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · doi:10.1515/jib-2018-0065 · Cited by 21
Attribute-guided prototype network for few-shot molecular property prediction
Hou, L., Xiang, H., Zeng, X., Cao, D., Zeng, L., & Song, B. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae394 · Cited by 21
Speck‐Planche, A. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0213 · Cited by 21
Peng, Y., Wu, Z., Yang, H., Cai, Y., Liu, G., Li, W., & Tang, Y. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.05.005 · Cited by 21
Gao, Z., Pan, Y., Ding, P., & Xu, R. (2022) · PubMed Central · Cited by 21
Yu, L., Xu, Z., Qiu, W., & Xiao, X. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107812 · Cited by 21
Zhu, J., Liu, Y., Zhang, Y., Chen, Z., She, K., & Tong, R. (2022) · Expert Systems with Applications · doi:10.1016/j.eswa.2022.119312 · Cited by 21
RECOMED: A comprehensive pharmaceutical recommendation system
Zomorodi, M., Ghodsollahee, I., Martin, J. H., Talley, N. J., Salari, V., Pławiak, P., Rahimi, K., & Acharya, U. R. (2024) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2024.102981 · Cited by 21
Drug repurposing improvement using a novel data integration framework based on the drug side effect
Lakizadeh, A., & Mir-Ashrafi, S. M. H. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100523 · Cited by 21
Wu, L., Fang, H., Qu, Y., Xu, J., & Tong, W. (2025) · Drug Safety · doi:10.1007/s40264-025-01520-1 · Cited by 20
Deep Learning Based Methods for Molecular Similarity Searching: A Systematic Review
Nasser, M., Yusof, U. K., & Salim, N. B. (2023) · Processes · doi:10.3390/pr11051340 · Cited by 20
Automatic Extraction of Adverse Drug Reactions from Summary of Product Characteristics
Shen, Z., & Spruit, M. R. (2021) · Applied Sciences · doi:10.3390/app11062663 · Cited by 20
Descriptor-Free Deep Learning QSAR Model for the Fraction Unbound in Human Plasma
Riedl, M., Mukherjee, S., & Gauthier, M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00129 · Cited by 20
BETA: a comprehensive benchmark for computational drug–target prediction
Zong, N., Li, N., Wen, A., Ngo, V., Yu, Y., Huang, M. S., Chowdhury, S., Jiang, C., Fu, S., Weinshilboum, R. M., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac199 · Cited by 20
Fast and effective molecular property prediction with transferability map
Yao, S., Song, J., Jia, L., Cheng, L., Zhong, Z., Song, M., & Feng, Z. (2024) · Communications Chemistry · doi:10.1038/s42004-024-01169-4 · Cited by 20
Chen, L., Lu, Y., Xu, J., & Zhou, B. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06102-7 · Cited by 20
Dietschmann, A., Schruefer, S., Westermann, S., Henkel, F. D. R., Castiglione, K., Willebrand, R., Adam, J., Ruland, J., Lang, R., Sheppard, D. C., et al. (2022) · mBio · doi:10.1128/mbio.01239-22 · Cited by 20
Research Progresses and Applications of Knowledge Graph Embedding Technique in Chemistry
Wang, C., Yang, Y., Song, J., & Nan, X. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00791 · Cited by 20
Jung, S. G., Jung, G., & Cole, J. M. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01862 · Cited by 20
In Silico Profiling of Clinical Phenotypes for Human Targets Using Adverse Event Data
Soldatos, T. G., Taglang, G., & Jackson, D. (2018) · Microarrays · doi:10.3390/ht7040037 · Cited by 20
Cristiano, G., Bota, P. M., Oliva, B., & Fernández‐Fuentes, N. (2021) · Database · doi:10.1093/database/baab068 · Cited by 20
DeCoST: A New Approach in Drug Repurposing From Control System Theory
Nguyen, T. M., Muhammad, S. A., Ibrahim‐Shaikh, S., Ma, L., Guo, J., Bai, B., & Zeng, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00583 · Cited by 20
In vitro to in vivo extrapolation for drug-induced liver injury using a pair ranking method
Liu, Z., Fang, H., Borlak, J., Roberts, R., & Tong, W. (2017) · ALTEX · doi:10.14573/altex.1610201 · Cited by 20
Rustandi, T., Prihandiwati, E., Nugroho, F., Hayati, F., Afriani, N., Alfian, R., Aisyah, N., Niah, R., Rahim, A., & As-Shiddiq, H. (2023) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2023.1274975 · Cited by 20
QuerioDALI: Question Answering Over Dynamic and Linked Knowledge Graphs
López, V., Tommasi, P., Kotoulas, S., & Wu, J. (2016) · Lecture notes in computer science · doi:10.1007/978-3-319-46547-0_32 · Cited by 20
Augmenting Polymer Datasets by Iterative Rearrangement
(2023) · doi:10.1021/acs.jcim.3c00144 · Cited by 19
Directions for Explainable Knowledge-Enabled Systems
Chari, S., Gruen, D. M., Seneviratne, O. W., & McGuinness, D. L. (2020) · Studies on the semantic web · doi:10.3233/ssw200022 · Cited by 19
Towards the routine use of in silico screenings for drug discovery using metabolic modelling
Bintener, T., Pacheco, M. P., & Sauter, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190867 · Cited by 19
Drug repurposing through joint learning on knowledge graphs and literaturePreprint
Alshahrani, M., & Hoehndorf, R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/385617 · Cited by 19
UniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels
Silberg, J., Swanson, K., Simon, E. P., Zhang, A., Ghazizadeh, Z., Ogden, S., Hamadeh, H. K., & Zou, J. (2024) · neural information processing systems · doi:10.52202/079017-0385 · Cited by 19
Huang, L., Liu, P., & Xiao-jie, H. (2025) · Toxicology · doi:10.1016/j.tox.2025.154064 · Cited by 19
Cheng, Z., Xu, D., Ding, D., & Ding, Y. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3354953 · Cited by 19
Shi, X.-X., Wang, Z.-Z., Sun, X., Wang, Y., Liu, H., Wang, F., Hao, G., & Yang, G. (2023) · Green Chemistry · doi:10.1039/d2gc03973g · Cited by 19
Web Resources for Discovery and Development of New Medicines
Bezhentsev, V., Druzhilovskiy, D. S., Ivanov, S. M., Filimonov, D. A., Sastry, G. N., & Poroikov, V. (2017) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-017-1563-x · Cited by 19
Drug Repurposing: Insights into Current Advances and Future Applications
Bhatia, T., & Sharma, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673266470231023110841 · Cited by 19
He, M., Shi, Y., Han, F., & Cai, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1448106 · Cited by 19
MDG-DDI: multi-feature drug graph for drug-drug interaction prediction
Li, W., Zhou, Y., Ma, W., Liang, W., & Tang, X. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06288-w · Cited by 19
Torshin, I. Y., Громова, О. А., Chuchalin, A. G., & Zhuravlev, Y. I. (2021) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2021.078 · Cited by 19
Relational Multi-Task Learning: Modeling Relations between Data and TasksPreprint
Cao, K., You, J., & Leskovec, J. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2303.07666 · Cited by 19
Zheng, Y., Peng, H., Zhang, X., Zhao, Z., Gao, X., & Li, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3238-y · Cited by 18
Zhang, H., Zhou, Y., Zhang, Z., Sun, H., Pan, Z., Mou, M., Zhang, W., Ye, Q., Hou, T., Li, H., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01793 · Cited by 18
Detecting potential signals of adverse drug events from prescription data
Zhan, C., Roughead, E. E., Liu, L., Pratt, N. L., & Li, J. (2020) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2020.101839 · Cited by 18
Das, S., Taylor, K., Beaulah, S. A., & Gardner, S. (2022) · Patterns · doi:10.1016/j.patter.2022.100496 · Cited by 18
Lakizadeh, A., & Babaei, M. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10382-z · Cited by 18
Butkiewicz, M., RESTREPO, N. A., Haines, J. L., & Crawford, D. C. (2016) · PubMed Central · Cited by 18
A Deep-Learning Proteomic-Scale Approach for Drug Design
Overhoff, B., Falls, Z., Mangione, W., & Samudrala, R. (2021) · Pharmaceuticals · doi:10.3390/ph14121277 · Cited by 18
Knowledge Graphs and Their Applications in Drug Discovery
James, T., & Hennig, H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3449-3_9 · Cited by 18
MoleHD: Efficient Drug Discovery using Brain Inspired Hyperdimensional Computing
Ma, D., Thapa, R., & Jiao, X. (2022) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm55620.2022.9995708 · Cited by 18
Deepthi, K., & Jereesh, A. S. (2021) · IEEE Access · doi:10.1109/access.2021.3063885 · Cited by 18
Empowering Dual-Level Graph Self-Supervised Pretraining with Motif Discovery
Yan, P., Song, K., Jiang, Z., Kang, Y., Lin, T., Sun, C., & Liu, X. (2024) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v38i8.28774 · Cited by 18
From Vision to Content: Construction of Domain-Specific Multi-Modal Knowledge Graph
Zhang, X., Sun, X., Xie, C., & Lun, B. (2019) · IEEE Access · doi:10.1109/access.2019.2933370 · Cited by 18
MoleHD: Ultra-Low-Cost Drug Discovery using Hyperdimensional ComputingPreprint
Ma, D., Thapa, R., & Jiao, X. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2106.02894 · Cited by 18
Predicting the side effects of drugs using matrix factorization on spontaneous reporting database
Fukuto, K., Takagi, T., & Tian, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-03348-y · Cited by 18
Detection of Adverse Drug Reactions using Medical Named Entities on Twitter.
MacKinlay, A., Aamer, H., & Yepes, A. J. (2017) · PubMed Central · Cited by 18
Modeling and insights into the structural characteristics of drug-induced autoimmune diseases
Guo, H., Zhang, P., Zhang, R., Hua, Y., Zhang, P., Cui, X., Huang, X., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1015409 · Cited by 18
Tanaka, Y., Chen, H. Y., Belloni, P., Gisladottir, U., Kefeli, J., Patterson, J., Srinivasan, A., Zietz, M., Sirdeshmukh, G., Berkowitz, J., et al. (2025) · Med · doi:10.1016/j.medj.2025.100642 · Cited by 17
Molinski, S. V., Shahani, V. M., MacKinnon, S. S., Morayniss, L. D., Laforet, M., Woollard, G., Kurji, N., Sanchez, C. G., Wodak, S. J., & Windemuth, A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.115 · Cited by 17
PGxDB: an interactive web-platform for pharmacogenomics research
Nguyen, T. T. D., Tanoli, Z., Hassan, S. S. M., Özcan, U. O., Caroli, J., Kooistra, A. J., Gloriam, D. E. I., & Hauser, A. S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1127 · Cited by 17
Bridging data and discovery: a survey on knowledge graphs in AI for science
Ding, K., Zhu, Z., Tang, Y., Feng, K., Zhuang, X., Yang, Y., Yang, Y., Du, H., Ni, Z., Wang, S., et al. (2026) · National Science Review · doi:10.1093/nsr/nwag140 · Cited by 17
Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response
Piñero, J., González-Pérez, A., Güney, E., Aguirre‐Plans, J., Sanz, F., Oliva, B., & Furlong, L. I. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00412 · Cited by 17
Reay, W. R., Shair, S. I. E., Geaghan, M. P., Riveros, C., Holliday, E. G., McEvoy, M., Hancock, S., Peel, R., Scott, R. J., Attia, J. R., et al. (2021) · eLife · doi:10.7554/elife.63115 · Cited by 17
Natsiavas, P., Boyce, R. D., Jaulent, M., & Koutkias, V. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00609 · Cited by 17
Han, J., Zhung, W., Jang, I., Lee, J., Kang, M. J., Lee, T. D., Kwack, S. J., Kim, K., Hwang, D., Lee, B.-W., et al. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-00992-8 · Cited by 17
Yan, D., Bao, S., Zhang, Z., Sun, J., & Zhou, M. (2024) · Nature Computational Science · doi:10.1038/s43588-024-00748-8 · Cited by 17
Drug-Target Prediction Based on Dynamic Heterogeneous Graph Convolutional Network
Xu, P., Wei, Z., Li, C., Yuan, J., Liu, Z., & Liu, W. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3441324 · Cited by 17
Discovering associations between adverse drug events using pattern structures and ontologies
Personeni, G., Bresso, E., Devignes, M., Dumontier, M., Smaïl‐Tabbone, M., & Coulet, A. (2017) · Journal of Biomedical Semantics · doi:10.1186/s13326-017-0137-x · Cited by 17
Nascimento, C. M. C., Moura, P. G., & Pimentel, A. S. (2023) · Digital Discovery · doi:10.1039/d2dd00136e · Cited by 17
DILIC: An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature
Rathee, S., MacMahon, M., Liu, A., Katritsis, N. M., Youssef, G., Hwang, W., Wollman, L., & Han, N. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.867946 · Cited by 17
SADR: Self-Supervised Graph Learning With Adaptive Denoising for Drug Repositioning
Jin, S., Zhang, Y., Yu, H., & Lu, M. (2024) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2024.3351079 · Cited by 17
Molecular Contrastive Pretraining with Collaborative Featurizations
Zhu, Y., Chen, D., Du, Y., Wang, Y., Liu, Q., & Wu, S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01468 · Cited by 17
Tiwari, S. P., Shi, W. Z., Budhathoki, S., Baker, J. S., Sekizkardes, A. K., Zhu, L., Kusuma, V. A., Hopkinson, D., & Steckel, J. A. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01232 · Cited by 17
Liang, X., Li, J., Fu, Y., Qu, L., Tan, Y., & Zhang, P. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104131 · Cited by 17
Afdhal, D., Ananta, K. W., & Hartono, W. S. (2020) · International Conference on Advanced Computer Science and Information Systems · doi:10.1109/icacsis51025.2020.9263166 · Cited by 17
PACIA: Parameter-Efficient Adapter for Few-Shot Molecular Property Prediction
Wu, S., Wang, Y., & Yao, Q. (2024) · International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2024/576 · Cited by 17
Liang, S., & Yu, H. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa495 · Cited by 17
Wang, L., Sun, C., Xu, X., Li, J., & Zhang, W. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad532 · Cited by 17
GAR: Graph adversarial representation for adverse drug event detection on Twitter
Shen, C., Li, Z., Chu, Y., & Zhao, Z. (2021) · Applied Soft Computing · doi:10.1016/j.asoc.2021.107324 · Cited by 17
Efficient Sharpness-Aware Minimization for Molecular Graph Transformer Models
Wang, Y., Zhou, K., Liu, N., Wang, Y., & Wang, X. (2024) · International Conference on Learning Representations · doi:10.48550/arxiv.2406.13137 · Cited by 17
Christ, P., Dubrall, D., Schmid, M. C., & Sachs, B. (2023) · Drug Safety · doi:10.1007/s40264-023-01355-8 · Cited by 17
Geometry-induced protein reorientation on the spikes of plasmonic gold nanostars
Rodrigues, R. L., Xie, F., Porter, A. E., & Ryan, M. P. (2020) · Nanoscale Advances · doi:10.1039/c9na00584f · Cited by 17
Giangreco, N. P., & Tatonetti, N. P. (2022) · Med · doi:10.1016/j.medj.2022.06.001 · Cited by 16
Molecular Motif Learning as a pretraining objective for molecular property prediction
Liu, Z., Wang, C., Zheng, S., Wu, C., Feng, H., Xu, L. M., Zheng, Y., Rong, L., & Li, P. (2025) · Nature Communications · doi:10.1038/s41467-025-66685-w · Cited by 16
Chen, H., Zhang, Z., & Zhang, J. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-03988-x · Cited by 16
Liu, J. Y. H., & Rudd, J. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-33655-5 · Cited by 16
Zhao, M., & Yang, C. C. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9646 · Cited by 16
Liu, X., Tian, R., Tao, H., Wu, J., Yang, L., Zhang, Y., & Meng, X. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175362 · Cited by 16
A review of SARS-CoV-2 drug repurposing: databases and machine learning models
Elkashlan, M., Ahmad, R. M., Hajar, M., Jasmi, F. A., Corchado, J. M., Nasarudin, N. A., & Mohamad, M. S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1182465 · Cited by 16
BiMPADR: A Deep Learning Framework for Predicting Adverse Drug Reactions in New Drugs
Li, S., Zhang, L., Wang, L., Ji, J., He, J., Zheng, X., Cao, L., & Li, K. (2024) · Molecules · doi:10.3390/molecules29081784 · Cited by 16
In Silico Databases and Tools for Drug Repurposing
Serçinoğlu, O., & Özbek, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00024-9 · Cited by 16
Recent computational drug repositioning strategies against SARS-CoV-2
Lu, L., Qin, J., Chen, J., Yu, N., Miyano, S., Deng, Z., & Li, C. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.017 · Cited by 16
Metadata
- Authors
- Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Copenhagen (DK)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-19
- Volume
- 44
- Issue
- D1
- Pages
- D1075-D1079
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702794
- OpenAlex
- W2145578524
- Cited by
- 1,451
- References
- 18
- Citations by year
- 2026: 123 · 2025: 199 · 2024: 194 · 2023: 160 · 2022: 156 · 2021: 183 · 2020: 131 · 2019: 111 · 2018: 82 · 2017: 74 · 2016: 37
- FWCI
- 51.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Molecular Biology Laboratory
- Novo Nordisk (NNF14CC0001)
- Novo Nordisk Fonden (NNF 14CC0001)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- SIDER, adverse drug reactions, drug safety, drug indications, package inserts, natural language processing, therapeutic target
- MeSH terms
- Drug Labeling, Internet, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.